Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Sarcoma 2Head & Neck 2Gynecologic 2Gastrointestinal 2Breast 2

Conditions

Urogenital Neoplasms 2Stomach Neoplasms 2Sarcoma 2Ovarian Neoplasms 2Lung Neoplasms 2Liver Neoplasms 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2

Interventions

fludarabine 4aldesleukin 4Cyclophosphamide 4pembrolizumab 3niraparib 2Riluzole 2olaparib 1motexafin gadolinium 1lenvatinib 1anlotinib 1Watchful Waiting 1Transurethral Resection of Prostate 1Specimen Handling 1Remote Patient Monitoring 1Pregnancy Tests 1Pemetrexed 1Paclitaxel 1Ocoxin 1Loperamide 1Imagery, Psychotherapy 1Human Papillomavirus DNA Tests 1Genetic Testing 1Fulvestrant 1Filgrastim 1Fecal Microbiota Transplantation 1Educational Status 1Drug Therapy 1Diffusion 1Colposcopy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Urogenital Neoplasms × Riluzole × Gynecologic × Clear all
NCT07447050 2026-03-03

Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

University of California, Irvine

Phase 2 Recruiting
24 enrolled
BreastGastrointestinalGynecologicHead & NeckSarcomaThoracic

Breast Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Sarcoma, Stomach Neoplasms, Urogenital Neoplasms, Colorectal Neoplasms

NCT06580002 2025-06-26

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

University of California, Irvine

Phase 2 Recruiting
51 enrolled
BreastGastrointestinalGynecologicHead & NeckSarcomaThoracic

Breast Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Sarcoma, Stomach Neoplasms, Urogenital Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡